Name: Neurizon Therapeutics (NUZ) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

NUZ

Pharmaceuticals, Biotechnology & Life Sciences

Neurizon Therapeutics

Short interest: 0.01%; −0.02 pp 30d; as of 27 Dec 2024
Reported shorts: 43.4K
Shares on issue: 491.906M

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

About Neurizon Therapeutics

Development of drug therapies for neurodegenerative diseases.

Company profile →

Neurizon Therapeutics (ASX:NUZ) has 0.01% of its shares on issue reported as short positions as of 27 Dec 2024, or about 43,356 shares. Over the past 30 days that figure has been broadly flat, and over 7 days it has been broadly flat. NUZ is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Short interest

History & FAQ →

Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.

Strategy fit

How each stock picker strategy reads NUZ today

Zanger BreakoutWatchScore 10rank 1663 of 1942
CAN SLIMNot a candidate
Minervini Trend TemplateWatchScore 16rank 1054 of 1716
Crowded-Short BreakoutWatchScore 15rank 653 of 1500
Quality compoundersWatchScore 12rank 1083 of 1669

Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →

NUZ fundamentals

In the year to 30 Jun 2026, Neurizon Therapeutics (ASX:NUZ) recorded revenue of A$0 and a net loss after tax of A$10.7M. A year earlier it recorded revenue of A$0 and a net loss after tax of A$16.6M. Figures are in AUD, the company's reporting currency; source: ASX (Markit) and Yahoo Finance, as at 14 Oct 2026.

Full statements, ratios and filings are on the Financials tab. Not financial advice.

Full financials →